XBIO stock news · Xenetic Biosciences
Get alerts for XBIO
Follow Xenetic Biosciences (XBIO) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for XBIO12 health care companies are changing in price before the market opens on Monday.
NeutralXenetic Biosciences shares fell 10.27% before Monday's open, but the story gives no company news explaining the drop. It does not change the picture of Xenetic Biosciences' business.
Xenetic Biosciences, Inc. shares new info about its upcoming deal with Santersus AG.
NeutralXenetic filed an 8-K updating its investor presentation for a proposed share exchange with Santersus. I read this as neutral because it shows progress but no binding terms.
On Tuesday, 12 health care stocks changed a lot, with Jaguar Health jumping 304.5% and Silexion Therapeutics dropping 3%.
NeutralThe article reports Xenetic Biosciences shares fell 16.39% intraday. It contains no company-specific news, so it does not change how we read Xenetic Biosciences.
Crude oil prices dropped more than 3%, while U.S. businesses stocked up in July.
Bad for XBIOAnnouncing an all-stock acquisition caused the stock to fall, as markets reacted to dilution and deal uncertainty.
12 health care companies are changing prices before the market opens on Wednesday.
NeutralThe article reports XBIO fell 33.49% to $2.84 in pre-market trading, but it gives no company news, so the report does not change how we read XBIO.
Xenetic Biosciences, Inc. has signed a deal to buy Santersus AG.
Bad for XBIOXenetic's agreement would hand control to Santersus holders and greatly dilute current Xenetic shareholders, a negative development for existing holders.